Source: StreetInsider

Press Release: Calliditas Therapeutics AB : Calliditas Therapeutics Capital Markets Day Today November 4

STOCKHOLM, Nov. 4, 2019 /PRNewswire/ -- Calliditas Therapeutics ("Calliditas") today hosts a Capital Markets Day in Stockholm, moderated by Lars Frick from Börsveckan. The Capital Markets Day takes place at GT...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Renee Aguiar-Lucander's photo - CEO of Calliditas

CEO

Renee Aguiar-Lucander

CEO Approval Rating

90/100

Calliditas is a pharmaceutical company that develops and commercializes therapeutics for the treatment of inflammatory kidney diseases. Read more